Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy

被引:78
作者
Campi, Irene [1 ,2 ,3 ]
Gennari, Luigi [4 ]
Merlotti, Daniela [4 ]
Mingiano, Christian [4 ]
Frosali, Alessandro [4 ]
Giovanelli, Luca [1 ,2 ,5 ]
Torlasco, Camilla [6 ,7 ]
Pengo, Martino F. [6 ,7 ]
Heilbron, Francesca [6 ,7 ]
Soranna, Davide [8 ]
Zambon, Antonella [8 ,9 ]
Di Stefano, Marta [1 ,2 ,5 ]
Aresta, Carmen [1 ,2 ,5 ]
Bonomi, Marco [1 ,2 ,5 ]
Cangiano, Biagio [1 ,2 ,5 ]
Favero, Vittoria [1 ,2 ,5 ]
Fatti, Letizia [1 ,2 ,5 ]
Perego, Giovanni Battista [6 ]
Chiodini, Iacopo [1 ,2 ,5 ]
Parati, Gianfranco [6 ,7 ]
Persani, Luca [1 ,2 ,5 ]
机构
[1] Ist Auxol Italiano, Dept Endocrine & Metab Dis, IRCCS, Via Magnasco 2, I-20149 Milan, Italy
[2] Ist Auxol Italiano, Lab Endocrine & Metab Res, IRCCS, Via Magnasco 2, I-20149 Milan, Italy
[3] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[4] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy
[5] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[6] Ist Auxol Italiano, Dept Cardiovasc Neural & Metab Sci, IRCCS, Milan, Italy
[7] Univ Milano Bicocca, Dept Med & Surg, I-20100 Milan, Italy
[8] IRCCS Ist Auxol Italiano, Biostat Unit, Milan, Italy
[9] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy
关键词
Vitamin D; COVID-19; Mortality; Interleukin-6; TOCILIZUMAB; DEFICIENCY; RISK;
D O I
10.1186/s12879-021-06281-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Vitamin D deficiency has been suggested to favor a poorer outcome of Coronavirus disease-19 (COVID-19). We aimed to assess if 25-hydroxyvitamin-D (25OHD) levels are associated with interleukin 6 (IL-6) levels and with disease severity and mortality in COVID-19. Methods We prospectively studied 103 in-patients admitted to a Northern-Italian hospital (age 66.1 +/- 14.1 years, 70 males) for severely-symptomatic COVID-19. Fifty-two subjects with SARS-CoV-2 infection but mild COVID-19 symptoms (mildly-symptomatic COVID-19 patients) and 206 subjects without SARS-CoV-2 infection were controls. We measured 25OHD and IL-6 levels at admission and focused on respiratory outcome during hospitalization. Results Severely-symptomatic COVID-19 patients had lower 25OHD levels (18.2 +/- 11.4 ng/mL) than mildly-symptomatic COVID-19 patients and non-SARS-CoV-2-infected controls (30.3 +/- 8.5 ng/mL and 25.4 +/- 9.4 ng/mL, respectively, p < 0.0001 for both comparisons). 25OHD and IL-6 levels were respectively lower and higher in severely-symptomatic COVID-19 patients admitted to intensive care Unit [(ICU), 14.4 +/- 8.6 ng/mL and 43.0 (19.0-56.0) pg/mL, respectively], than in those not requiring ICU admission [22.4 +/- 1.4 ng/mL, p = 0.0001 and 16.0 (8.0-32.0) pg/mL, p = 0.0002, respectively]. Similar differences were found when comparing COVID-19 patients who died in hospital [13.2 +/- 6.4 ng/mL and 45.0 (28.0-99.0) pg/mL] with survivors [19.3 +/- 12.0 ng/mL, p = 0.035 and 21.0 (10.5-45.9) pg/mL, p = 0.018, respectively). 25OHD levels inversely correlated with: i) IL-6 levels (rho - 0.284, p = 0.004); ii) the subsequent need of the ICU admission [relative risk, RR 0.99, 95% confidence interval (95%CI) 0.98-1.00, p = 0.011] regardless of age, gender, presence of at least 1 comorbidity among obesity, diabetes, arterial hypertension, creatinine, IL-6 and lactate dehydrogenase levels, neutrophil cells, lymphocytes and platelets count; iii) mortality (RR 0.97, 95%CI, 0.95-0.99, p = 0.011) regardless of age, gender, presence of diabetes, IL-6 and C-reactive protein and lactate dehydrogenase levels, neutrophil cells, lymphocytes and platelets count. Conclusion In our COVID-19 patients, low 25OHD levels were inversely correlated with high IL-6 levels and were independent predictors of COVID-19 severity and mortality.
引用
收藏
页数:13
相关论文
共 52 条
[21]   Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection [J].
Hernandez, Jose L. ;
Nan, Daniel ;
Fernandez-Ayala, Marta ;
Garcia-Unzueta, Mayte ;
Hernandez-Hernandez, Miguel A. ;
Lopez-Hoyos, Marcos ;
Munoz-Cacho, Pedro ;
Olmos, Jose M. ;
Gutierrez-Cuadra, Manuel ;
Ruiz-Cubillan, Juan J. ;
Crespo, Javier ;
Martinez-Taboada, Victor M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (03) :E1343-E1353
[22]   SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor [J].
Hoffmann, Markus ;
Kleine-Weber, Hannah ;
Schroeder, Simon ;
Krueger, Nadine ;
Herrler, Tanja ;
Erichsen, Sandra ;
Schiergens, Tobias S. ;
Herrler, Georg ;
Wu, Nai-Huei ;
Nitsche, Andreas ;
Mueller, Marcel A. ;
Drosten, Christian ;
Poehlmann, Stefan .
CELL, 2020, 181 (02) :271-+
[23]  
Holick MF., 2020, PLOS ONE, V15, P1
[24]   The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality [J].
Ilie, Petre Cristian ;
Stefanescu, Simina ;
Smith, Lee .
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 32 (07) :1195-1198
[25]  
Jolliffe DA, 2021, THORAX, V76, pA60, DOI [10.1016/S2213-8587(21)00051-6, 10.1136/thorax-2020-BTSabstracts.105]
[26]   VDR Attenuates Acute Lung Injury by Blocking Ang-2-Tie-2 Pathway and Renin-Angiotensin System [J].
Kong, Juan ;
Zhu, Xiangdong ;
Shi, Yongyan ;
Liu, Tianjing ;
Chen, Yunzi ;
Bhan, Ishir ;
Zhao, Qun ;
Thadhani, Ravi ;
Li, Yan Chun .
MOLECULAR ENDOCRINOLOGY, 2013, 27 (12) :2116-2125
[27]   Metabolic Healthy Obesity, Vitamin D Status, and Risk of COVID-19 [J].
Li, Shu ;
Cao, Zhi ;
Yang, Hongxi ;
Zhang, Yuan ;
Xu, Fusheng ;
Wang, Yaogang .
AGING AND DISEASE, 2021, 12 (01) :61-71
[28]   Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society [J].
Lips, Paul ;
Cashman, Kevin D. ;
Lamberg-Allardt, Christel ;
Bischoff-Ferrari, Heike Annette ;
Obermayer-Pietsch, Barbara ;
Bianchi, Maria Luisa ;
Stepan, Jan ;
Fuleihan, Ghada El-Hajj ;
Bouillon, Roger .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 180 (04) :P23-P54
[29]   BLOOD VITAMIN CONCENTRATIONS DURING THE ACUTE-PHASE RESPONSE [J].
LOUW, JA ;
WERBECK, A ;
LOUW, MEJ ;
KOTZE, TJV ;
COOPER, R ;
LABADARIOS, D .
CRITICAL CARE MEDICINE, 1992, 20 (07) :934-941
[30]   RETRACTED: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection [J].
Maghbooli, Zhila ;
Sahraian, Mohammad Ali ;
Ebrahimi, Mehdi ;
Pazoki, Marzieh ;
Kafan, Samira ;
Tabriz, Hedieh Moradi ;
Hadadi, Azar ;
Montazeri, Mahnaz ;
Nasiri, Mehrad ;
Shirvani, Arash ;
Holick, Michael F. .
PLOS ONE, 2020, 15 (09)